Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On September 11, 2022, Dr. Christine A. White, Chair and member of the Board of
Directors (the "Board") of MEI Pharma, Inc. (the "Company") and member of the
Nominating and Corporate Governance Committee of the Board (the "Committee"),
informed the Company that, after more than 12 years of service, she has decided
to formally retire and thus she does not intend to stand for reelection at the
Company's fiscal year 2023 annual meeting of stockholders (the "Annual
Meeting"). Dr. White will continue to serve as Chair and as a director and
member of the Committee until the date of the Annual Meeting. Dr. White's
intention not to stand for reelection following the end of her current term was
not the result of any disagreement with the Company on any matter relating to
the Company's operations, policies or practices. The Company thanks Dr. White
for her years of service as Chair of the Board and as a director.
The Board does not currently expect to nominate or appoint a new director to the
Board following the Annual Meeting and therefore, following the Annual Meeting,
the size of the Board will be eight directors. In addition, the Board is
considering the appointment of a successor to the position of Chair following
the Annual Meeting but no formal decision has been made as of this date.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
MEI PHARMA, INC. 
